Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-04-27

Clinical Trial Update: Research Study Comparing Insulin Degludec to Insulin Detemir, Together With Insulin Aspart, in Pregnant Women With Type 1 Diabetes [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing insulin degludec to insulin detemir, each in combination with insulin aspart, in pregnant women with type 1 diabetes has completed, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Insulin aspart (insulin aspart)
  • Insulin detemir (insulin detemir)
  • insulin degludec (insulin degludec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 1 | Phase 3 | Status: COMPLETED | Results posted: 2022-04-27